• 1. Trebatická, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol®. Eur Child Adolesc Psychiatry. 2006;15:329-335.

  • 2. Dvoráková M, et al. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep. 2006;11(4):163-72.

  • 3. Dvoráková M, et al. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (Pycnogenol®). Nutr Neurosci. 2007;10(3-4):151-157.

  • 4. Weyns AS, et al. Clinical investigation of French maritime pine bark extract on attention-deficit hyperactivity disorder as compared to methylphenidate and placebo: Part 1: efficacy in a randomised trial. J Funct Foods. 2022;97:105246.

  • 5. Weyns A-S, et al. Enhancing pediatric attention-deficit hyperactivity disorder treatment: exploring the gut microbiota effects of French maritime pine bark extract and methylphenidate intervention. Front. Nutr. 2024;11:1422253.

  • 6. Elhossiny RM, et al. Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial. BMC Psychiatry. 2023 Nov 9;23(1):823. doi: 10.1186/s12888-023-05324-4.

  • 7. Millichap JG, Yee MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics. 2012;129(2):330- 337.

  • 8. Nazarova VA, et al. Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Frontiers in Pharmacology. 2022 ;13:1066988.

  • 9. Bradley S, et al. Treatments for ADHD in Children and Adolescents: A Systematic Review. Pediatrics April 2024; 153 (4): e2024065787. 10.1542/peds.2024-065787.

  • 10. Atika Pharma. Neutop®. Disponible en: https://atikapharma.com/products/neutop

  • 11. Hemamy M, et al. The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: a randomized controlled trial. BMC Pediatr. 2021 May 12;21(1):230. doi: 10.1186/s12887-021-02683-3.

  • 12. Ghoreishy, S.M, et al. Zinc status in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis of observational studies. Sci Rep 11, 14612 (2021). https://doi.org/10.1038/s41598-021-94124-5

  • 13. Hosoi M, et al. Pycnogenol® supplementation in minimal cognitive dysfunction. J Neurosurg Sci. 2018;62(3):279-284.

  • 14. Verlaet AAJ, et al. Rationale for Dietary Antioxidant Treatment of ADHD. Nutrients. 2018;10(4):405. doi:10.3390/nu10040405.

  • 15. Belcaro G, et al. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress. Journal of Neurosurgical Sciences. 2015 Dec;59(4):437-446. PMID: 26635191.

  • 16. Norris CM, et al. Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury. Exp Neurol. 2016 Feb;276:5-12. doi: 10.1016/j.expneurol.2015.11.006. Epub 2015 Nov 29. PMID: 26607913; PMCID: PMC4715929.

  • 17. Fan B, et al. Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation. PLoS One. 2015 Sep 14;10(9):e0137837

  • 18. Stough C, Pase MP. Improving Cognition in the Elderly With Nutritional Supplements. Curr Dir Psychol Sci. 2015;24(3):177-183. doi:10.1177/0963721414567494

  • 19. Belcaro G, et al. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35–55. J Neurosurg Sci. 2014;58(4):239-24

  • 20. Ryan J, et al. An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol. 2008 Jul;22(5):553-62.

  • 21. Chovanová Z, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res. 2006 Sep;40(9):1003-10.

  • 22. Peng QL, et al. Pycnogenol® protects neurons from amyloid-peptide-induced apoptosis. Brain Res Mol Brain Res. 2002;104(1):55-65. doi:10.1016/S0169- 328X(02)00263-2.

  • 23. Liu F, et al. Pycnogenol protects vascular endothelial cells from-amyloid-induced injury. Biol Pharm Bull. 2000;23(6):735-737. doi:10.1248/bpb.23.735.

  • 24. Liu F, Zhang Y, Lau BHS. Pycnogenol Improves Learning Impairment and Memory Deficit in Senescence-Accelerated Mice. Journal of Anti-Aging Medicine. 1999;2(4):349-355. doi:10.1089/rej.1.1999.2.349

  • 25. Heimann SW. Pycnogenol for ADHD? J Am Acad Child Adolesc Psychiatry. 1999;38(4):357-358. doi:10.1097/00004583-199904000-0000.

  • 26. Weichmann F, et al. Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies. Front. Nutr. 11:1389374. doi: 10.3389/fnut.2024.1389374.

  • 27. Luzzi R, Belcaro G, Zulli C, Cesarone MR, Cornelli U, Dugall M, Hosoi M, Feragalli B. Pycnogenol® supplementation improves cognitive function, attention and mental performance in students. Panminerva Med. 2011 Sep;53(3 Suppl 1):75-82. PMID: 22108481.

  • 28. Kirova AM, et al. Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? A systematic qualitative review of the literature with meta-analysis. Psychiatry Res. 2019;274:75-90.

  • 29. Velilla Picazo M, et al. Beneficios y riesgos de la discontinuación del tratamiento durante las vacaciones de verano en niños de edad escolar con trastorno por déficit de atención con hiperactividad. Revista de Psiquiatría Infanto-Juvenil. 2012; 29(3):40–51.

  • 30. Nourredine M, et al. Pharmacological interventions for ADHD: a systematic review and dose–effect network metaanalysis. The Lancet Psychiatry, 13, 485-495.